Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy
Clinical trial NCT03950050 · COMPLETED
Trial details
- NCT number
- NCT03950050
- Sponsor
- Shaare Zedek Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2022-11-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.